SEC Form SC 13G/A filed

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:

[   ] Rule 13d-1(b)

[X] Rule 13d-1(c)

[   ] Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 

* Beneficial ownership percentage is based upon 73,094,901 shares of common stock, $0.0001 par value per share (“Common Stock”), of Flotek Industries, Inc., a Delaware corporation (the “Company”), issued and outstanding as of November 13, 2020, based on information reported by the Company in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on November 16, 2020.  Newtyn Management, LLC (“Newtyn Management”) is the investment manager to Newtyn Partners, LP (“NP”) and Newtyn TE Partners, LP (“NTE”).  As of December 31, 2020, NP held 1,708,808 shares of Common Stock and NTE held 1,080,251 shares of Common Stock.  

Newtyn Management, as the investment manager to NP and NTE, possesses the sole power to direct the vote and the sole power to direct the disposition of the 2,789,059 shares of Common Stock held in the aggregate by NP and NTE.  As a result of the foregoing, for purposes of Reg. Section 240.13d-3, Newtyn Management may be deemed to beneficially own 2,789,059 shares of Common Stock, or approximately 3.8% of the shares of Common Stock deemed to be issued and outstanding as of December 31, 2020.

* Beneficial ownership percentage is based upon 73,094,901 shares of common stock, $0.0001 par value per share (“Common Stock”), of Flotek Industries, Inc., a Delaware corporation (the “Company”), issued and outstanding as of November 13, 2020, based on information reported by the Company in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on November 16, 2020.  As of December 31, 2020, Newtyn Partners, LP held 1,708,808 shares of Common Stock, or approximately 2.3% of the Common Stock deemed issued and outstanding as of December 31, 2020..

 _________________________________________________________________________________

__________________________________________________________

 *     This Schedule 13G is being jointly filed by (a) NP and (b) Newtyn Management, the investment manager to (y) NP, which is the holder of 1,708,808 shares of Common Stock of the Company, and (z) NTE, which is the holder of 1,080,251 shares of Common Stock of the Company.

The 2,789,059 shares of Common Stock held in the aggregate by NP and NTE, which constitutes approximately 3.8% of the shares of Common Stock deemed to be issued and outstanding as of December 31, 2020, may deemed to be beneficially owned indirectly by Newtyn Management, LLC, as the investment manager to NP and NTE.

 As of December 31, 2020, NP held 1,708,808 shares of Common Stock, or approximately 2.3% of the Common Stock deemed issued and outstanding as of December 31, 2020.

The foregoing beneficial ownership percentage is based upon information reported by the Company in its Quartly Report on Form 10-Q filed with the Securities and Exchange Commission on November 16, 2020.

SIGNATURE

          After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Attention: Intentional misstatements or omissions of fact constitute

Federal criminal violations (See 18 U.S.C. 1001)

Exhibit Index